Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Kentanix Supra International Tbk. (KSIX) vs UBC Medical Indonesia Tbk. (LABS)

Kentanix Supra International Tbk.Trading
UBC Medical Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Kentanix Supra International Tbk. dan UBC Medical Indonesia Tbk.: Kentanix Supra International Tbk. diperdagangkan di Rp408 (kapitalisasi pasar 880,79 M, volume 24 jam 367,7 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb). Perbedaan utamanya: Kentanix Supra International Tbk. lebih besar dari sisi kapitalisasi pasar, dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (843 rb vs 367,7 rb). Mana yang lebih baik tergantung tujuan investasimu.

KSIXLABS
Kapitalisasi Pasar
880,79 M635,95 M
Volume
367,7 rb843 rb
Lot
3,68 rb8,43 rb
Perputaran
147,39 jt137,6 jt
Harga Rata-rata
400,85163,22
Nilai Transaksi
147,39 jt137,6 jt
Harga Ekuilibrium Indikatif
408165
Volume Ekuilibrium Indikatif
17246

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

KSIX
Lihat detail
LABS
Lihat detail

Tentang Kentanix Supra International Tbk.

PT Kentanix Supra International Tbk (the Company) was established based on Notarial Deed No. 41 dated October 27, 1980 of Samsul Hadi, S.H., as amended by Deed No. 25 dated April 8, 1981 and Deed No. 10 dated October 9, 1981 of the same Notary. The Company commenced its commercial operations in 1985. PT Badra Arta, a company incorporated in Indonesia, is the parent entity of the Company.

Selengkapnya di halaman KSIX

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS